Immunity and hospital infections

Area of Science:

• Medical Microbiology
• Immunology
• Oncology

Background:

• Antibiotic resistance in hospital-acquired bacterial strains is a growing concern.
• Gram-negative bacteria like Klebsiella, Serratia, Pseudomonas, Proteus, and E. coli are increasingly resistant to antibiotics.
• Developing alternative strategies to combat these infections is crucial.

Purpose of the Study:

• To evaluate the efficacy of a phenol-treated vaccine in preventing wound infections in colorectal cancer patients undergoing surgery.
• To assess the impact of pre-existing immunoreactivity on vaccine effectiveness.

Main Methods:

• A phenol-treated vaccine was prepared from common hospital bacterial strains.
• Colorectal cancer patients were immunized intramuscularly 7-10 days before surgery.
• The incidence of post-operative wound infections was monitored to assess vaccine efficiency.

Main Results:

• Vaccine treatment was associated with a reduced incidence of wound infections.
• The best outcomes were observed in patients with strong or normal baseline immunoreactivity.
• No immunospecificity was detected in relation to the vaccine treatment.

Conclusions:

• Vaccination with a phenol-treated bacterial vaccine may be a viable strategy to reduce surgical site infections in colorectal cancer patients.
• Patient immunoreactivity is a key factor influencing the effectiveness of this immunization approach.
• Further research is needed to understand the mechanisms of action and optimize vaccine development.